Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids and personalized hearing care products, as well as offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
| Revenue | $22,419,000,000 |
| Net Income | $2,387,000,000 |
| Free Cash Flow | $3,301,000,000 |
| Book Value / Share | $44.40 |
| Total Liabilities | $22,806,000,000 |
| Total Equity | $9,564,000,000 |
| Debt / Equity | 1.64 |
| Current Ratio | 1.63 |
| Interest Coverage | 7.23 |
| Working Capital | $3,826,000,000 |
Core multiples and valuation signals — useful to compare vs peers.
| P/E (TTM) | 24.04 |
| Industry P/E | N/A |
| Forward P/E | 24.04 |
| P/B | 6.00 |
| Price / Sales | 2.56 |
| P / FCF | 17.39 |
| EV / EBITDA | 12.40 |
| Graham Number | $104.34 |
| DCF (placeholder) | — |
| Gross Margin | 76.23% |
| Operating Margin | 21.02% |
| Net Margin | 10.65% |
| ROIC | 13.36% |
| Asset Turnover | 0.69 |
| RSI (14) | 6.77 |
| SMA 50 | 18.83 |
| SMA 200 | 18.92 |
| MACD | -0.30 |
| Signal | NEUTRAL |
| Name | Title |
|---|---|
| Mr. Søren Nielsen | CEO, President & Member of Executive Board (1970) |
| Mr. René Schneider M.Sc | CFO, President of Group Services & Member of Executive Board (1973) |
| Mr. Niels Wagner | President of Hearing Care & Member of Executive Board (1971) |
| Sara Munch Andersen | Head of Group Privacy & Compliance (—) |
| Stine Brandenhof | Group General Counsel (—) |
| Ms. Trine Kromann-Mikkelsen | Vice President of Corporate Communication and Sustainability (—) |
| Mr. Finn Mohring | Senior Vice President of R&D (1965) |
| Mr. Peter Pudselykke | Head of Investor Relations (Leave of Absence) (—) |
No news available for this company.